Peter P. Pfreundschuh
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Peter P. Pfreundschuh
Peter P. Pfreundschuh is recorded as CFO at Voyager Therapeutics, Inc. (VYGR). Voyager Therapeutics, Inc. reported in an 8-K filed April 2, 2024 that Peter P. Pfreundschuh resigned as Chief Financial Officer, effective April 12, 2024. Voyager Therapeutics, Inc. reported in an 8-K filed September 7, 2022 that Peter P. Pfreundschuh was appointed Chief Financial Officer, effective September 19, 2022.
“Mr. Pfreundschuh resigned from his position of Chief Financial Officer and from any and all other positions he holds as an officer of the Company or an officer, employee or director of any of its subsidiaries, effective on April 12, 2024, or such earlier date as may be mutually agreed upon in writing by the Company and Mr. Pfreundschuh (as applicable, such date, the "Transition Date")”
“On September 7, 2022, Voyager Therapeutics, Inc. (the “Company”) and Peter P. Pfreundschuh entered into an employment agreement (the “Pfreundschuh Agreement”), pursuant to which Mr. Pfreundschuh agreed to serve as the Chief Financial Officer of the Company, with the first date of employment to commence on September 19, 2022 (the “Pfreundschuh Commencement Date”).”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2022-09-19–present
-
2022-09-19–2024-04-12
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Voyager Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Alfred Sandrock CEO, Board Member
- Alfred Sandrock, M.D., Ph.D. CEO, Board Member
- Michael Higgins CEO, Board Member
- Nathan Jorgensen, Ph.D., M.B.A. CFO
- Robin Swartz CFO, COO
- Glenn Pierce, M.D., Ph.D. CTO, Board Member
- Gregory Shiferman General Counsel
- Amy Quinlan Chief Accounting Officer
- Julie Burek Chief Accounting Officer
- Nathan Jorgensen Chief Accounting Officer
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.